Lisa I Glasser

Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis

J. Meyers, B. Patterson, S. Jabbour, 2022, Diabetes care.

Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019

B. Patterson, P. Buck, Chi-Chang Chen, 2021, Human vaccines & immunotherapeutics.

Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance

A. Maldonado, Lisa I Glasser, Maribel Miranda Co-van der Mee, 2021, Therapeutic Advances in Vaccines and Immunotherapy.

Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study

V. Willey, M. Verduzco-Gutierrez, M. Pollack, 2023, Current medical research and opinion.